PubMed Health⌕ Search

Biomedical subjects

Emily Chew

Publications and source records attributed to Emily Chew.

4 recordsLinked to original sources

Metal-organic frameworks from zinc sulfite clusters, chains, and sheets: 4-connected, (3,4)-connected 3-D frameworks and 2-D arrays of catenane-like interlocking rings.

Even though open-framework solids have been made in a variety of compositions such as silicates, phosphates, germanates, borates, and phosphites, few are known that are based on trigonal-pyramidal sulfite anions. We report here the first synthetic and structural studies of metal-organic framework materials in the zinc sulfite composition. It is demonstrated here that Zn2+ and SO32- can form various neutral inorganic subunits that can be 0-D clusters, 1-D chains, or 2-D sheets. These inorganic subunits of different dimensionality can subsequently be connected into extended frameworks of higher dimensionality through bifunctional ligands. In (ZnSO3)2en, infinite corrugated ZnSO3 layers are pillared by ethylenediamine (en) molecules into a 3-D network that can be classified as a (3,4)-connected net based on tetrahedral Zn nodes and trigonal-pyramidal S nodes. In (ZnSO3)pip, infinite ZnSO3 chains are cross-linked with piperazine molecules into a 3-D framework that can be classified as 4-connected net based on tetrahedral Zn nodes only. In (ZnSO3)2(TMDPy)2, (ZnSO3)2 dimers are doubly bridged by trimethylenedipyridine molecules into an infinite chain with a string of circles. Each circle along the chain is interlocked with another circle from a chain in the perpendicular direction, creating a 2-D pattern with an infinite-square array of catenane-like units.

Molecular Structure↗

Vitamin E in the treatment of uveitis-associated macular edema.

PURPOSE: To investigate whether high-dose alpha-tocopherol (vitamin E) could reduce vision loss and retinal thickening associated with uveitis-associated cystoid macular edema. DESIGN: A double-masked, randomized study. METHODS: Uveitis patients with macular edema seen at the NIH were randomized and received either 1600 IU/day of vitamin E or placebo for 4 months. Visual acuity and retinal thickening were collected for the efficacy and the safety of the high dose of vitamin E. RESULTS: Changes in visual acuity and retinal thickening. CONCLUSIONS: Four-month oral supplementation with 1600 IU/d of vitamin E had no apparent effect on uveitis-associated macular edema or visual acuity in this small study.

Adult↗

Age-related cataract in a randomized trial of beta-carotene in women.

PURPOSE: To examine the development of age-related cataract in a trial of beta-carotene supplementation in women. METHODS: The Women's Health Study is a randomized, double-masked, placebo-controlled trial originally designed to test the balance of benefits and risks of beta-carotene (50 mg on alternate days), vitamin E, and aspirin in the primary prevention of cancer and cardiovascular disease among 39,876 female health professionals aged 45 years or older. The beta-carotene component of the trial was terminated early after a median treatment duration of 2.1 years. Main outcome measures were visually-significant cataract and cataract extraction, based on self-report confirmed by medical record review. RESULTS: There were 129 cataracts in the beta-carotene group and 133 in the placebo group (relative risk [RR] = 0.95, 95% CI 0.75-1.21). For cataract extraction, there were 94 cases in the beta-carotene group and 89 cases in the placebo group (RR = 1.04, 95% CI 0.78-1.39). Subgroup analyses suggested a possible beneficial effect of beta-carotene in smokers. CONCLUSIONS: These randomized trial data from a large population of apparently healthy female health professionals indicate that two years of beta-carotene treatment has no large beneficial or harmful effect on the development of cataract during the treatment period.

Aged↗